PÁCAL, Lukáš, Veronika DVOŘÁKOVÁ, Martina RAUDENSKÁ, Katarína KURICOVÁ, Jaromír GUMULEC, Jan SVOJANOVSKÝ, Jitka ŘEHOŘOVÁ, Branislav RUTTKAY-NEDECKÝ, Ondřej ZÍTKA, René KIZEK, Michal MASAŘÍK and Kateřina KAŇKOVÁ. Blood levels of heavy metals and metallothionein in type 2 diabetics with kidney disease. In Diabetes - a Threat to Mankind. 2013.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Blood levels of heavy metals and metallothionein in type 2 diabetics with kidney disease
Authors PÁCAL, Lukáš, Veronika DVOŘÁKOVÁ, Martina RAUDENSKÁ, Katarína KURICOVÁ, Jaromír GUMULEC, Jan SVOJANOVSKÝ, Jitka ŘEHOŘOVÁ, Branislav RUTTKAY-NEDECKÝ, Ondřej ZÍTKA, René KIZEK, Michal MASAŘÍK and Kateřina KAŇKOVÁ.
Edition Diabetes - a Threat to Mankind, 2013.
Other information
Type of outcome Conference abstract
Confidentiality degree is not subject to a state or trade secret
Changed by Changed by: Mgr. Lukáš Pácal, Ph.D., učo 14473. Changed: 13/6/2013 10:20.
Abstract
Oxidative stress and subsequent activation of antioxidant mechanisms (both enzymatic and nonenzymatic) is well established in type 2 diabetes (T2DM). Metallothionein (MT) is a protein binding heavy metal ions (primarily zinc). MT substantially affects zinc metabolism and thus insulin secretion by beta-cell. Zinc levels are often decreased in diabetics due to its increased renal clearance. Association of polymorphism in the gene for zinc transporter (ZnT-8) with T2DM in genome wide association study (Sladek R et al. Nature 2007) underlines the role of zinc for glucose metabolism. We aimed to determine blood levels of selected heavy metals, MT, antioxidants and relevant SNPs in type 2 diabetics with kidney disease (at least microalbuminuric) and healthy subjects.
Links
NT13198, research and development projectName: Pentózový cyklus jako potenciální nový terapeutický cíl v prevenci diabetických komplikací
Investor: Ministry of Health of the CR
PrintDisplayed: 29/7/2024 20:31